September 2, 2019
Daiichi Sankyo was stepping up its promotional activities through a series of channels for its pain treatment Tarlige (mirogabalin) in June after the Lyrica (pregabalin) contender hit the market in mid-April, an industry survey showed. The “Impact Track” detailing track...read more